|Articles|September 16, 2008

Physician's Money Digest

  • July31 2003
  • Volume 10
  • Issue 14

Strategize: Trim an Overgrown Portfolio

Dr. David Moehring, a Washingtonstate orthopedic surgeon, is like manyof his fellow doctors who have watchedtheir investments plummet in the bearmarket. Once valued at nearly $1.4 million,the doctor's portfolio is reportedlynow down to about $600,000.

Wall Street Journal

With stocks and mutual funds in 7 differentretirement accounts (such as anIRA, 403(b), 457, and Keogh), he haswatched some investments fall drastically—like his Sirna Therapeutics stock andhis Munder mutual fund, which dropped45% last year, 49% 2 years ago, and 55%3 years ago. Approaching retirement age,he told a reporter thathe'll be working a few more years than heoriginally planned.

His wife, who has her own portfolio of50 stocks, has watched her own investmentsfall to approximately $80,000. InMarch 2000, they were worth $180,000.

Wall

Street Journal

Unlike his fellow physicians, though, Dr.Moehring had a unique opportunity tohave his family's portfolios reviewed by apanel of 3 experts. Profiled by the in its "Can This Portfolio BeSaved?," Dr. Moehring received the adviceof Rande Spiegelman, vice president offinancial planning at Charles Schwab & Co;Linda Lubitz, a certified financial planner™practitioner in Miami, Fla; and MitchellKurtz, senior vice president of Advest inGarden City, NY. Here is a summary of theiradvice as reported in the newspaper:

• Decrease the amount ofstocks—Spiegelman and Kurtz both feel30% of assets should be in bonds and 10%in money market/cash; Lubitz says 80%stocks and 20% bonds. As for the stocks,Spiegelman feels they should be divided30% large cap, 15% small and mid cap,and 15% international; Kurtz feels 40%large cap and 20% small and mid cap; andLubitz feels 45% large cap, 15% small andmid cap, and 20% international. They allthink the Moehrings have too muchinvested in risky tech and biotech sectorsand that international investments aretoo focused on Asia and Japan.

• Kill the losers—The advisorsseemed to feel it was a good idea tounload some stocks. Stocks to drop included:Applied Materials, Immucor, Corning,Blue Rhino, and Palm. Stocks to keepincluded: Ariba, Cisco Systems, Invitrogen,Intuit, Visx, PepsiCo, Klamath First Bancorp,Amgen, Walt Disney, Home Depot,General Electric, and Pfizer.

• Buy better stock bets—Spiegelmansays to trade some stocks for bettercompanies in the same industries. ReplaceRobert Mondavi with Church & Dwight orProctor & Gamble; and replace Cima Labswith Bausch & Lomb. Kurtz says to pick upKimberly-Clark, Adobe Systems, Walgreen,Bank of America, and DominionResources. Lubitz recommends lookinginto exchange-traded funds, which tradelike stocks but offer less risk and generallytrack an index or sector.

• Own the best funds—While Mrs.Moehring can buy and sell as she pleases,Dr. Moehring's retirement plans havevery restricted flexibility. As a result,Spiegelman says to "own the best funds ineach plan" and compensate for limitationsby using the more flexible IRA orKeogh. He recommends funds like ArtisanInternational, Oakmark International,American Century Equity Growth, JanusGrowth & Income, and Loomis SaylesSmall Cap Growth. He also likes theLehman Brothers Aggregate Bond Index.Lubitz likes the Pimco Real Return bondfund. She says Dr. Moehring should dropB-class shares of various Munder and Aimfunds and his Fidelity Japan. Instead buyCalamos Growth & Income, Dodge & CoxStock, Bjurman Micro-Cap Growth andAmerican Funds Europacific Growth orDreyfus Premier Emerging Markets Rshares, respectively. Finally, Kurtz likes theEaton Vance Government Obligationsbond and the ING Principal Protection VIIfund.

Articles in this issue

over 17 years ago

IRS EYES LEASING

over 17 years ago

CAR INSURANCE SHOPPING

over 17 years ago

DOCTORS ONLINE

over 17 years ago

CREDIT CARD HOME

over 17 years ago

RETIRE IN A HEALTHY STATE

over 17 years ago

TRUSTS & MORE

over 17 years ago

DID YOU KNOW?

over 17 years ago

PRN: Harness Human Nature's Quirks

over 17 years ago

WHAT PRIVILEGE?

Latest CME